Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trial.
Saved in:
| Title: | Subcutaneous interleukin-2, interferon alpha-2b and 5-fluorouracil in metastatic renal cell carcinoma as second-line treatment after failure of previous immunotherapy: a phase II trial. |
|---|---|
| Authors: | Ravaud, A.1 alain.ravaud@chu-bordeaux.fr, Trufflandier, N.1, Ferrière, J.M.2, Debled, M.1, Palussière, J.3, Cany, L.1, Gaston, R.4,5, Mathoulin-Pélissier, S.6, Bui, B.N.1, Ferrière, J M (AUTHOR), Palussière, J (AUTHOR), Mathoulin-Pélissier, S (AUTHOR) |
| Source: | British Journal of Cancer. 12/15/2003, Vol. 89 Issue 12, p2213-2218. 6p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
